Black Currant Seed Oil GLA.

Both oils supply gamma-linolenic acid, which bypasses the slow delta-6 desaturase step and is elongated to dihomo-gamma-linolenic acid. Black currant seed oil additionally carries stearidonic acid and alpha-linolenic acid, so the doses add rather than duplicate.

Borage oil carries roughly twice the GLA of black currant seed oil and feeds the identical elongation step to DGLA. Combining them is a dose decision on one pathway, not two mechanisms.

Supplemental GLA raises DGLA, but some DGLA is desaturated onward to arachidonic acid by delta-5 desaturase. EPA suppresses that step, which is why GLA oils are conventionally formulated with EPA.

GLA and stearidonic acid carry three and four double bonds and oxidise readily in the capsule and in membranes. Tocopherol breaks the lipid peroxidation chain, which is why polyunsaturated oils are routinely formulated with it.

Delta-6 desaturase activity depends on magnesium, zinc and pyridoxine as cofactors. Magnesium supports the enzyme that sits upstream of the GLA the oil supplies directly.

Zinc is required for normal delta-6 desaturase function, the rate-limiting conversion of linoleic acid to GLA. Low zinc status is a textbook reason that endogenous GLA production falls.

Pyridoxine supports delta-6 desaturase activity in the essential fatty acid pathway. It is a standing cofactor pairing in GLA formulas.

Both GLA-derived series-1 eicosanoids and EPA-derived series-3 eicosanoids lower platelet aggregation tendency. Stacking the two oils has an additive effect on normal clotting time and matters for anyone already taking a blood thinner.

Ginkgolide B antagonises platelet activating factor, and GLA-derived series-1 prostaglandins also reduce platelet aggregation. The two add on the same normal clotting parameter.

Garlic organosulfur compounds inhibit platelet aggregation through thromboxane pathways, the same direction as GLA-derived series-1 eicosanoids. Combining them adds on normal clotting.

Gamma-linolenic acid is elongated to dihomo-gamma-linolenic acid, which can either be converted onward to arachidonic acid by delta-5 desaturase or used as a substrate for series-1 eicosanoids. Eicosapentaenoic acid competes for delta-5 desaturase and for the downstream cyclooxygenase and lipoxygenase enzymes, which shifts where dihomo-gamma-linolenic acid ends up. This is well characterised enzymology and it is the standard reason GLA oils and marine oils are combined.

Docosahexaenoic acid competes with the n-6 series for incorporation into membrane phospholipids and for the same desaturase and elongase capacity. Black currant seed oil is unusual among GLA sources because it also carries alpha-linolenic and stearidonic acid, giving it n-3 content of its own. The interaction is about substrate competition, not about one oil improving the other.

Linoleic acid is the precursor GLA is normally made from, via delta-6 desaturase, and a large linoleic acid load competes for the same downstream elongation and desaturation steps. Supplemental GLA bypasses the delta-6 step entirely, which is the whole rationale for taking it preformed. A high linoleic acid background diet therefore changes the context rather than blocking the ingredient.

Polyunsaturated oils propagate lipid peroxidation chains once initiated, and mixed tocopherols terminate those chains both in the bottle and in the membrane. This is why nearly every seed oil softgel contains them. The role is protecting the oil and the lipids it joins, not adding a separate action.

Rosemary extract standardised for carnosic acid is used as an oxidation retardant in polyunsaturated oils, often alongside tocopherols because the two work at different points of the chain. Its presence is a shelf-life decision made by the manufacturer. It is not a reason to expect anything different in the person taking it.

Triglyceride oils require bile salt micelles and pancreatic lipase before the fatty acids can be absorbed, so bile availability is upstream of any effect a seed oil could have. Ox bile is used where that capacity is reduced, for instance after gallbladder removal. The mechanism is digestive, and it applies to every oil equally.

Pancreatic lipase hydrolyses the triglyceride at the sn-1 and sn-3 positions to release free fatty acids and a monoglyceride, which is the form actually taken up. GLA in black currant seed oil is esterified in triglycerides and must go through that step. Supplemental lipase addresses the same bottleneck from the other side.

Medium-chain triglycerides are used as a carrier because they are liquid at room temperature, resist oxidation, and provide the lipid load that triggers bile release. They dilute the GLA content per gram, which is a labelling consideration a formulator manages deliberately. Carrier choice affects the product, not the fatty acid chemistry.

Phospholipid emulsifiers help disperse an oil phase and are used in emulsions and some softgel fills. The effect is on the physical state of the product in the gut. It should not be read as a claim about the fatty acid itself.

Curcuminoids act on cyclooxygenase and lipoxygenase signalling, the same enzyme families that convert dihomo-gamma-linolenic acid and arachidonic acid to their eicosanoid products. Combining them touches one pathway from two directions, which supports a normal inflammatory response rather than acting on any named condition. No trial of this specific pairing grounds a magnitude.

Boswellic acids act on 5-lipoxygenase, one of the two branches that GLA-derived dihomo-gamma-linolenic acid can enter. The pairing is mechanistically coherent for supporting joint comfort and mobility. It is a pathway argument, not a measured combination effect.

Willow bark supplies salicylates that act on platelet cyclooxygenase, and GLA-rich oils shift eicosanoid balance in a direction that also touches platelet aggregation. The combined effect on clotting tendency deserves flagging rather than encouraging, particularly around surgery or alongside anticoagulant medication. This is a caution derived from established pharmacology, not a synergy to seek out.

Nattokinase acts on fibrin, and a GLA-rich oil can shift platelet eicosanoid balance, so the two together push on haemostasis by different routes. Anyone on anticoagulant or antiplatelet therapy should have this pairing reviewed by their clinician. Flagged as an additive effect, not recommended as a combination.

Gingerols act on thromboxane synthesis in platelets, overlapping with the eicosanoid shift a GLA oil produces. The direction of the two effects is the same, so the combination is worth noting. Grounded in established pharmacology rather than in a study of the pair.

Krill oil supplies EPA and DHA in phospholipid form, competing with n-6 derivatives for desaturase capacity and membrane incorporation just as fish oil does. The phospholipid presentation changes the carrier, not the competition. Combining the two is a way to supply both series at once and should be described that way.

Alpha-linolenic acid from flax competes with linoleic acid and with GLA-derived intermediates for delta-6 and delta-5 desaturase and for elongase capacity. Black currant seed oil already contains alpha-linolenic and stearidonic acid, so adding flax stacks the same substrate class. The interaction is competition for shared enzymes, which is neither good nor bad in itself.

Astaxanthin is a lipid-phase antioxidant that spans the membrane bilayer, the same environment polyunsaturated fatty acids are incorporated into and where peroxidation would begin. Pairing it with a polyunsaturated oil is an oxidative-stability rationale. Confidence sits at mechanism level.

Hyaluronic acid governs water binding in the dermis while fatty acids contribute to the lipid barrier of the stratum corneum, two different parts of skin hydration. Products pair them for that complementarity. The grounding is physiological rather than a trial of the combination.

Ceramides are structural lipids of the skin barrier, and linoleic acid derivatives are required for normal ceramide and acylceramide assembly. The two therefore sit on the same barrier lipid pathway. No combination measurement is cited, so this stays at the level of shared biochemistry.

Biotin-dependent acetyl-CoA carboxylase runs the first committed step of fatty acid synthesis, and biotin also has a settled role in normal skin and hair. Formulators group it with seed oils on that basis. The pairing is compositional rather than tested.

Ascorbate regenerates the tocopheryl radical back to tocopherol at the lipid-water interface, which is what allows a small amount of vitamin E to protect a large amount of polyunsaturated lipid. It is also the cofactor for the prolyl and lysyl hydroxylases in collagen assembly. Both roles are established without needing a trial of the pairing.